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31 Abstract  
32 Malaria  diagnostic  testing  in  Africa  is  threatened  by  Plasmodium  falciparum  parasites  
33 lacking  histidine-rich  protein  2  ( pfhrp2 )  and  3  ( pfhrp3 )  genes.  Among  12,572  subjects  
34 enrolled  along  Ethiopia’s  borders  with  Eritrea,  Sudan,  and  South  Sudan  and  using  
35 multiple  assays,  we  estimate  HRP2-based  rapid  diagnostic  tests  would  miss  9.7%  
36 (95%  CI  8.5-11.1)  of  falciparum  malaria  cases  due  to  pfhrp2  deletion.  Established  
37 and  novel  genomic  tools  reveal  distinct  subtelomeric  deletion  patterns,  
38 well-established  pfhrp3  deletions,  and  recent  expansion  of  pfhrp2  deletion.  Current  
39 diagnostic  strategies  need  to  be  urgently  reconsidered  in  Ethiopia,  and  expanded  
40 surveillance  is  needed  throughout  the  Horn  of  Africa.   
2  
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41 Plasmodium  falciparum  strains  that  evade  diagnosis  by  rapid  diagnostic  tests  
42 (RDTs)  represent  a  major  threat  to  malaria  control  and  elimination  efforts 1,2 .  Malaria  
43 RDTs  detect  antigens  produced  by  Plasmodium  parasites,  including  P.  falciparum  
44 histidine-rich  protein  2  (HRP2),  parasite  lactate  dehydrogenase  (LDH),  and  aldolase.  
45 HRP2  has  advantages  over  other  biomarkers  due  to  its  abundance  in  the  
46 bloodstream,  repetitive  binding  epitopes,  and  falciparum-specificity 3,4 .  Most  
47 HRP2-based  RDTs  also  exhibit  some  cross-reactivity  to  a  closely  related  protein  
48 (HRP3) .  HRP2-based  RDTs  are  currently  the  predominant  malaria  diagnostic  test  
49 employed  throughout  sub-Saharan  Africa 5–7 .   
50 Deletion  mutations  involving  the  histidine-rich  protein  2  and/or  3  ( pfhrp2/3 )  
51 genes  allow  parasite  strains  to  escape  HRP2-based  RDT  detection 8,9 .  First  described  
52 in  clinical  samples  from  Peru  in  2010,  these  subtelomeric  deletions  on  chromosomes  
53 8  ( pfhrp2 )  and  13  ( pfhrp3 )  are  frequently  large  (≥20kb),  encompass  multiple  genes,  
54 and  are  difficult  to  study  using  existing  methods 9–11 .  Improved  PCR  and  serological  
55 approaches  can  be  used  to  increase  confidence  in  deletion  prevalence  
56 estimates 12–14 ,  but  our  understanding  of  the  evolutionary  history  of  pfhrp2/3- deleted  
57 P.  falciparum  is  limited  and  largely  informed  by  analysis  of  a  small  number  of  
58 microsatellite  markers 15–17 .  Recent  genomic  analyses  have  begun  to  expand  our  
59 understanding  of  pfhrp2/3- deleted  P.  falciparum 18–20   but  continue  to  be  hindered  by  
60 the  challenges  of  assembling  the  highly  repetitive  and  paralogous  sequences  of  P.  
61 falciparum ’s  subtelomeres 21 .  New  tools  are  needed  to  support  surveillance  of  
62 pfhrp2/3  deletions  and  to  determine  their  true  prevalence  and  the  forces  impacting  
63 their  evolution  and  spread.   
64 Increasing  reports  of  these  “diagnostic  resistant”  pfhrp2/3- deleted  parasites  in  
3  
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65 Africa  in  2017-2018  prompted  calls  for  urgent  surveillance  in  affected  regions,  
66 including  countries  in  the  Horn  of  Africa  like  Ethiopia 15,22–25 .  Ethiopia  is  Africa’s  
67 second  most  populous  country,  and  68%  of  its  population  is  at  risk  of  malaria  
68 exposure 26 .  P.  falciparum  infection  accounts  for  the  majority  of  malaria  deaths 27   and  
69 approximately  70%  of  all  cases 26 .  RDTs  were  first  introduced  in  Ethiopia  in  2004,  and  
70 the  country’s  current  test-treat-track  strategy  requires  parasitological  confirmation  
71 either  by  quality  microscopy  or  RDT  prior  to  antimalarial  treatment 28 .  P. 
72 falciparum-Plasmodium  vivax  (HRP2/Pv-specific-LDH)  combination  RDTs  are  the  
73 sole  diagnostic  test  used  in  most  settings.  Over  the  last  decade,  Ethiopia  has  
74 achieved  remarkable  progress  in  the  fight  against  malaria  through  strong  
75 preventative  and  case  management  interventions,  including  engagement  of  
76 volunteers  to  provide  diagnostic  services  at  a  local  level 28 .  Reports  of  highly  
77 prevalent  pfhrp2/3- deleted  parasites  in  neighboring  Eritrea  suggest  that  these  gains  
78 could  be  threatened 15,24 .  Rapid  assessment  of  the  epidemiology  of  pfhrp2/3  deletions  
79 in  Ethiopia  and  surrounding  regions  is  required  to  determine  whether  a  change  in  
80 malaria  diagnostic  testing  policy  is  warranted.   
81 Here,  we  describe  the  first  prospective,  multi-site  study  of  pfhrp2/3- deleted  P.  
82 falciparum  in  sub-Saharan  Africa  based  on  WHO’s  pfhrp2/3  deletion  surveillance  
83 protocol 29 ,  released  in  2018  to  encourage  a  harmonized  and  representative  
84 approach  to  pfhrp2/3  deletion  surveillance  and  accurate  reporting.  Including  sites  
85 spanning  Ethiopia’s  borders  with  Eritrea,  Sudan,  and  South  Sudan,  we  apply  both  
86 established  and  novel  genomic  tools  to  determine  the  genetic  epidemiology  of  
87 pfhrp2/3- deleted  P.  falciparum,  confirming  deletions  using  multiple  PCR  assays 14 ,  an 
88 ultrasensitive  bead-based  immunoassay  for  antigen  detection 13 ,  whole-genome  
4  
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89 sequencing  (WGS) 30 ,  and/or  molecular  inversion  probe  (MIP)   deep  sequencing 31 .  
90 Using  a  MIP  panel  designed  for  high-throughput  pfhrp2/3  genotyping,  we  map  and  
91 categorize  deletion  breakpoints  and  evaluate  their  flanking  regions  for  evidence  of  
92 recent  evolutionary  pressure  favoring  pfhrp2/3- deleted  parasites  in  Ethiopia.  
93   
94 RESULTS   
95 Study  Population  and  RDT  Results  
96 A  total  of  12,572  study  participants  (56%  male,  44%  female)  between  the  
97 ages  of  0  to  99  years  who  presented  with  one  or  more  of  symptoms  consistent  with  
98 malaria  at  108  health  facilities  in  the  Amhara,  Tigray,  and  Gambella  regions  between  
99 November  2017  and  April  2018  were  enrolled  ( Table  1 ).  Median  participant  age  was  
100 19  years  (interquartile  range  [IQR]:  8-30).  From  the  same  finger  prick,  participants  
101 were  tested  with  two  RDTs,  including  the  routine  HRP2/Pv-specific-LDH  RDT  
102 combination  test  [CareStart  Pf/Pv  RDT  (Access  Bio,  Somerset,  NJ;  product  code  RM  
103 VM-02571)]  and  the  survey  HRP2/Pf-specific-LDH  RDT  [SD  Bioline  Malaria  Ag  P.f.  
104 RDT  (Alere,  Waltham,  MA;  product  code  05FK90)].  
105 Overall,  2,714  (22%)  study  participants  were  P.  falciparum  positive  by  at  least  
106 one  RDT  (any  HRP2  or  Pf-LDH  positive  band);  among  these,  361  (13.3%;  95%  
107 confidence  interval  [CI]  12.1-14.7%)  had  a  discordant  RDT  profile  suggestive  of  
108 pfhrp2/3- deleted  P.  falciparum  infection,  which  was  defined  as  HRP2-negative  by  
109 both  RDTs  but  Pf-LDH  positive.  Among  the  2,714  samples  that  were  P.  falciparum  
110 positive  by  RDT,  the  northern  region  of  Tigray  had  the  highest  proportion  of  
111 infections  with  discordant  RDT  profiles  at  140/689  (20.4%;  95%  CI  17.5-23.7%),  
112 followed  by  Amhara  with  211/1342  (15.8%;  13.9-17.8)  and  Gambella  with  10/683  
5  
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113 (1.5%;  0.7-2.8),  as  shown  in  Figure  1 .   
114   
115 Pfhrp2/3  deletion  PCR  genotyping   
116 820  samples  with  complete  demographic  and  clinical  data  from  Amhara  (n  =  
117 524),  Tigray  (n  =  225),  and  Gambella  (n  =  71)  underwent  molecular  analysis.  These  
118 samples  were  collected  from  subjects  with  the  discordant  RDT  profile  and  a  subset  
119 of  subjects  with  other  RDT  results  ( Supplementary  Figure  1 ),  including  a  randomly  
120 selected  248/361  (68.7%)  of  those  with  the  discordant  RDT  profile  of  interest  
121 (HRP2-,  Pf-LDH+),  as  well  as  465/2115  (22.0%)  randomly  selected  P.  falciparum  
122 RDT  HRP2  positives  (HRP2+,  Pf-LDH+)  as  controls.  The  remaining  107  samples  
123 included  90  with  inconclusive  HRP2  results  (HRP2+  by  only  1  RDT,  of  which  67  were  
124 Pf-LDH-  and  23  were  Pf-LDH+)  and  17  negative  controls  (HRP2-,  Pf-LDH-).  
125 Quantitative  real-time  PCR  (qPCR)  targeting  the  P.  falciparum  lactate  
126 dehydrogenase  ( pfldh )  gene  confirmed  parasitemia  in  731/820  (89%)  samples,  with  
127 a  geometric  mean  (GM)  of  1,390.7  parasites/µL  (geometric  standard  deviation  
128 [geoSD]:  9.8).  Further  analysis  was  restricted  to  the  610  samples  with  >100  
129 parasites/µL  to  avoid  misclassification  of  pfhrp2/3  deletions  due  to  low  parasitemia  
130 ( Supplementary  Figure  2 );  176  (28.9%)  had  the  discordant  RDT  profile.   
131 Infection  by  pfhrp2/3- negative  parasites  was  common  among  these  610  
132 subjects  when  assessed  by  PCR,  with  355  (58%;  95%  CI  54-62)  lacking  detectable  
133 pfhrp2  and/or  pfhrp3,  and  136  (22%;  19-26)  lacking  both  pfhrp2  and  pfhrp3 .  For  
134 those  lacking  only  one  gene,  pfhrp3 -negative  infections  [192  (31%;  28-35)  
135 pfhrp2+/pfhrp3 -]  were  more  prevalent  than  pfhrp2 -negative  infections  [27  (4.4%;  3-6)  
136 pfhrp2 -/ pfhrp3+ ] .  Concordance  between  pfhrp2- negative  PCR  results  and  the  
6  
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137 discordant  RDT  profile  was  good  (Cohen’s  kappa  0.66).  Overall,  among  samples  
138 with  the  discordant  RDT  profile,  64.8%  (95%  CI  57-72)  were  pfhrp2-/3-  and  8.0%  
139 (5-13)  pfhrp2-/3+ ,  with  an  additional  15.9%  (11-22)  pfhrp2+/3-  ( Supplementary  
140 Figure  3 ).  Interestingly,  of  samples  HRP2+  by  both  RDTs,  pfhrp3  could  not  be  
141 amplified  in  42.6%  (38-48).  We  observed  expected  agreement  between  the  results  of  
142 pfhrp2/3  PCR  assays,  RDTs,  and  a  bead-based  HRP2  immunoassay  applied  to  a  
143 randomly  selected  subset  of  samples  (see  Supplementary  Results,  Table  2 ).  No  
144 associations  between  pfhrp2/3  PCR  result  and  age,  sex,  or  parasitemia  were  
145 identified  ( Supplementary  Table  1 ).  
146   
147 Pfhrp2/3  deletion  prevalence  estimates  
148 Incorporating  RDT  and  PCR  results,  we  estimated  that  9.7%  (95%  CI  
149 8.5-11.1)  of  all  P.  falciparum  infections  across  all  study  sites  would  have  
150 false-negative  HRP2-based  RDT  results  due  to  pfhrp2  deletions.  Regional  
151 prevalence  of  false-negative  RDTs  due  to  pfhrp2- deleted  parasites  varied,  with  the  
152 highest  estimates  in  Tigray  (14.9%;  12.5-17.7),  followed  by  Amhara  (11.5%;  
153 9.8-13.4)  and  Gambella  (1.1%;  0.6-2.0).  Our  prevalence  estimates  only  include  
154 samples  with  both  the  discordant  RDT  profile  and  a  pfhrp2- negative  call  by  PCR.  
155 Parasites  with  a  deletion  of  pfhrp2  but  intact  pfhrp3  and  sufficient  cross-reactive  
156 HRP3  to  trigger  a  positive  HRP2  band  on  either  RDT  are  not  included  in  these  
157 estimates.  Thus,  the  estimated  prevalence  of  false-negative  RDT  results  caused  by  
158 pfhrp2  deletions  likely  underestimates  the  true  prevalence  of  pfhrp2- deleted  
159 parasites  in  this  study.   
160   
7  
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161 Pfhrp2/3  deletion  characterization  using  MIP  sequencing  
162 To  enable  mapping  of  pfhrp2/3  deletion  regions  and  population  genetic  
163 analyses  in  large-scale  epidemiological  studies,  we  developed  a  targeted  panel  of  
164 241  MIPs  for  highly  multiplexed  deep  sequencing  of  pfhrp2,  pfhrp3,  and  flanking  
165 genes  on  chromosomes  8  and  13.  A  tiled  design  strategy  was  employed  that  
166 involved  multiple,  overlapping  probes  spanning  each  gene  target.  We  detected  244  
167 of  273  targets  with  sufficient  mapping  quality  and  depth  across  multiple  segments  of  
168 both  pfhrp2  and  pfhrp3  and  their  flanking  regions,  spanning  positions  1,344,451  to  
169 1,397,773  and  2,780,863  to  2,853,533  of  chromosomes  8  and  13,  respectively.  
170 Fourteen  total  probes  were  used  to  target  different  segments  of  pfhrp2  (n  =  8  
171 probes)  and  pfhrp3  (n  =  6).  Among  P.  falciparum  PCR-positive  samples  collected  
172 from  926  subjects  and  subjected  to  MIP  capture  and  sequencing,  375  (40.5%)  had  
173 sufficient  depth  of  coverage  to  make  high-confidence  calls.  In  total,  43,541,045  reads  
174 were  devoted  to  this  sample  set,  or  roughly  half  of  a  single  NextSeq  550  mid-output  
175 flow  cell.  The  median  parasite  density  for  samples  successfully  called  using  MIP  
176 sequencing  was  5,077  p/µL  (SD:  1.6  x  10 4 ),  compared  to  264  p/µL  (SD:  5.9  x  10 3 )  for  
177 samples  with  failed  MIP  calls.  Analysis  of  variant-called  MIP  sequences  confirmed  
178 mixed  infections  with  complexity  of  infection  ≥2  in  only  45  (12%)  subjects;  the  
179 majority  (n=330,  88%)  were  infected  by  a  single  P.  falciparum  strain.  
180 Among  367  (97.9%)  MIP-called  samples  with  matching  PCR  data,  85  (23.2%)  
181 were  pfhrp2-/3-  by  PCR.  MIP  sequencing  results  indicated  that  126/367  (34.3%;  95%  
182 CI  30-39)  were  pfhrp2-,  264/367  (71.9%;  67-76)  pfhrp3-,  and  116/367  (31.6%;  27-37)  
183 pfhrp2-/3-  by  MIP  sequencing  ( Figure  2,  Table  2 ).  Receiver-operator  curve  analysis  
184 indicated  the  optimal  parasite  density  threshold  above  which  samples  had  sufficient  
8  
  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250503doi: medRxiv preprint 
  
185 coverage  for  MIP  calling  was  approximately  925  p/µL,  although  this  threshold  is  
186 project-specific  and  is  expected  to  improve  with  additional  sequencing  effort  
187 ( Supplementary  Figure  4 ).  
188   
189 Comparison  of  pfhrp2/3  MIP  sequencing  to  PCR,  HRP2  immunoassay,  and  
190 whole-genome  sequencing  results  
191 Of  samples  called  pfhrp2 -  by  MIP  sequencing,  82.0%  were  pfhrp2-  by  PCR  
192 and  73.3%  had  the  discordant  RDT  profile.  Similarly,  of  samples  called  pfhrp3-  by  
193 MIP  sequencing,  76.7%  were  pfhrp3-  by  PCR.  While  differences  between  
194 genotyping  results  were  apparent  and  expected  due  to  differences  in  targets  and  
195 methodologies  (PCR  is  better  suited  for  samples  with  low  parasite  density  than  MIP  
196 sequencing),  there  was  overall  strong  concordance  between  RDT,  PCR,  and  MIP  
197 results  (Table  2) .  Comparison  of  results  from  MIP  and  PCR  pfhrp2/3  deletion  
198 genotyping  revealed  excellent  agreement  between  the  two  approaches  for  pfhrp2  
199 (Cohen’s  kappa:  0.82)  and  good  agreement  for  pfhrp3  (Cohen’s  kappa:  0.63).  
200 Comparison  to  the  bead-based  HRP2  immunoassay  results  provided  
201 additional  confidence  in  the  validity  of  our  pfhrp2/3  deletion  calls  using  MIP  
202 sequencing.  175  MIP-called  samples  also  had  bead-based  antigen  detection  results  
203 available.  Despite  fundamental  differences  in  the  targets  of  these  two  approaches  
204 ( pfhrp2  gene  versus  HRP2  antigen,  which  can  linger  after  clearance  of  infection), 32   
205 observed  agreement  between  the  two  methods  was  consistent  with  expectation.  Of  
206 those  samples  pfhrp2 +  by  MIP  sequencing,  94.1%  were  HRP2+  by  bead-based  
207 antigen  immunoassay,  whereas  79.5%  of  those  pfhrp2 -  by  MIPs  were  also  HRP2-  by  
208 the  immunoassay.   
9  
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209 We  used  whole-genome  sequencing  (WGS)  to  evaluate  pfhrp2/3  MIP  
210 sequencing  results  and  breakpoint  regions.  Among  14  samples  subjected  to  both  
211 WGS  and  MIP  sequencing,  median  WGS  depth  of  coverage  was  20  reads/locus  
212 (range  4-38).  While  the  distribution  of  aligned  reads  was  uneven  in  the  regions  
213 flanking  pfhrp2  and  pfhrp3 ,  visual  inspection  of  WGS  coverage  supported  13  (93%)  
214 pfhrp2  and  14  (100%)  pfhrp3  deletion  calls  made  using  MIP  sequencing  data  
215 ( Figure  3 ).  For  the  single  discordant  pfhrp2  deletion  call  (lab  ID:  1314),  pfhrp2  PCR  
216 results  were  consistent  with  the  MIP  sequencing  result.  Precise  mapping  of  
217 breakpoint  regions  using  WGS  was  not  possible  due  to  regions  of  very  high  
218 coverage  (“jackpotting”)  resulting  from  selective  whole-genome  amplification  and  low  
219 coverage  due  to  ambiguous  read  mapping  to  repetitive  and  paralogous  loci.  
220 However,  breakpoint  regions  identified  using  MIPs  were  consistent  with  WGS  
221 coverage  centromeric  to  pfhrp2  and  pfhrp3  on  chromosomes  8  and  13,  respectively,  
222 with  the  exception  of  calls  in  chromosome  13’s  multi-copy  28S  rRNA  gene.  
223 Discordance  in  these  calls  was  expected  due  to  ambiguous  mapping  of  short-read  
224 sequences  to  a  multi-copy  gene.  MIP  results  from  well-characterized  lab  strains  3D7  
225 ( pfhrp2+/3+ ),  DD2  ( pfhrp2-/3+ ),  and  HB3  ( pfhrp2+/3- )  were  consistent  with 
226 whole-genome  alignments  of  published  short-read  data.  Telomeric  deletion  
227 breakpoint  assessment  was  limited  by  a  small  number  of  successful  MIP  targets  
228 telomeric  to  both  genes.  However,  the  concordance  in  pfhrp2/3  deletion  calls  and  
229 centromeric  deletion  breakpoint  regions  by  MIP  and  WGS  techniques  confirmed  the  
230 utility  of  MIPs  for  identifying  pfhrp2/3  deletions  and  determining  their  extent  and  
231 breakpoint  regions.  
232   
10  
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233 Pfhrp2/3  deletion  breakpoint  profiling  
234 Compared  to  PCR,  bead-based  immunoassay,  or  RDT  diagnosis,  MIP  
235 sequencing  was  unique  in  its  ability  to  reveal  distinct  subtelomeric  structural  profiles  
236 along  chromosomes  8  and  13  into  which  samples  could  be  categorized:  three  for  
237 pfhrp2 +  samples  (chr8-P1,  chr8-P2,  chr8-P3),  one  for  pfhrp 2-  (chr8-P4),  one  for  
238 pfhrp3 +  (chr13-P1),  and  three  for  pfhrp3 -  (chr13-P2,  chr13-P3,  chr13-P4)  ( Figure  2 ).  
239 All  pfhrp2-  samples  had  the  same  subtelomeric  structural  profile  (chr8-P4),  although  
240 two  other  subtelomeric  deletions  were  identified  on  chromosome  8  that  did  not  
241 involve  pfhrp2  (chr8-P2,  chr8-P3).  These  deletions  involve  members  of  the  rifin  and  
242 stevor  gene  families,  as  well  as  genes  of  unknown  function.  
243 The  structural  profile  of  most  samples  identified  as  pfhrp3-  (chr13-P3  and  
244 chr13-P4)  differed  in  the  presence  or  absence  of  a  segment  of  chromosome  13  
245 directly  telomeric  to  pfhrp3  (position  2,852,540  -  2,853,533)  encoding  a  member  of 
246 the  acyl-coA  synthetase  family  ( PF3D7_1372400 ) .  All  chr13-P3  and  chr13-P4  
247 deletions  resulted  in  loss  of  genes  with  roles  in  red  blood  cell  invasion  
248 ( PF3D7_1371700,  serine/threonine  kinase  and  member  of  the  FIKK  family;  
249 PF3D7_1371600,  erythrocyte  binding-like  protein  1  [ EBL-1 ]) , 33,34   while  they  were  
250 present  in  all  chr13-P1  ( pfhrp3- intact)  parasites.  The  chr13-P2  deletion  profile  was  
251 observed  in  only  one  sample  from  Amhara’s  Metema  district.  We  did  not  observe  an  
252 association  between  subtelomeric  structural  profile  and  the  number  of  symptoms  
253 experienced  by  subjects  ( Supplementary  Figure  5,  Supplementary  Results )  or  
254 geographic  region  ( Supplementary  Table  4 ).   
255   Analysis  of  25  genomes  from  P.  falciparum  samples  collected  in  Ethiopia  in  
256 2013  and  2015  and  available  in  the  MalariaGEN  database  ( Supplementary  Figures 
11  
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257 6-7 )  uncovered  chromosome  13  subtelomeric  structural  profiles  similar  to  those  
258 identified  by  MIP  sequencing:  9  samples  with  coverage  consistent  with  chr13-P3  
259 ( pfhrp3- deleted),  2  samples  with  chr13-P4  ( pfhrp3- deleted),  and  14  samples  with  
260 chr13-P1  ( pfhrp3- intact). 19   
261   
262 Genetic  signatures  of  evolutionary  selection  
263 Extended  haplotype  homozygosity  (EHH)  statistics  revealed  signatures  of  
264 recent  positive  selection  in  the  flanking  region  centromeric  to  pfhrp2  deletions  on  
265 chromosome  8  but  not  in  flanking  regions  around  pfhrp3  deletions  on  chromosome  
266 13 35 .  91  and  17  biallelic  SNPs  within  the  28kb  and  27kb  regions  centromeric  to  
267 pfhrp2  and  pfhrp3  deletions,  respectively,  were  used  to  calculate  EHH  statistics.  327  
268 samples  with  pfhrp2  deletion  calls  using  MIP  sequencing  and  sufficient  variant  data  
269 were  included  in  the  EHH  analysis,  including  212  pfhrp2- intact  and  115  
270 pfhrp2 -deleted  haplotypes.  EHH  remained  very  high  for  parasites  with  the  pfhrp2  
271 deletion  (0.968)  along  the  entire  28kb  analyzed,  whereas  homozygosity  around  the  
272 pfhrp2- intact  (wild-type)  allele  quickly  broke  down  ( Figure  4A ).  A  similar  pattern  was  
273 observed  when  deletion  profiles  were  analyzed  separately;  chr8-P4  EHH  remained  
274 high  and  chr8-P1-P3  EHH  quickly  broke  down  ( Supplementary  Figure  8 ).  
275 We  further  confirmed  high  EHH  around  the  pfhrp2  deletion  allele  using  WGS  
276 data.  Comparing  23  whole-genome  sequenced  samples  from  this  study  and  the  25  
277 published  MalariaGEN  samples  described  above,  we  were  able  to  extend  our  
278 analysis  and  confirm  an  EHH  length  of  >143kb  centromeric  to  the  deletion  
279 (Supplementary  Figure  9A) .  These  findings  suggest  a  recent  selective  sweep,  
12  
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280 indicative  of  strong  evolutionary  pressure  favoring  pfhrp2- deleted  P.  falciparum 
281 parasites.  
282 A  different  pattern  was  observed  in  the  regions  flanking  pfhrp3  ( Figure  4B ) .  
283 162  samples  with  pfhrp3  deletion  calls  using  MIP  sequencing  and  sufficient  variant  
284 data  were  included  in  the  EHH  analysis,  including  37  pfhrp3- intact  and  125  
285 pfhrp3 -deleted  haplotypes  with  three  distinct  subtelomeric  structural  profiles.  No  
286 variant  calls  were  made  in  the  15.5  kb  region  immediately  centromeric  to  pfhrp3  to  
287 avoid  ambiguity  in  read  mapping  to  the  duplicated  DNA  segment  containing  
288 multicopy  genes  including  5.8S,  28S  rRNA.  EHH  quickly  decreased  below  0.5  for  
289 pfhrp3  deletion  alleles  as  well  as  the  pfhrp3- intact  allele  within  1  kb  of  available  
290 SNPs.  When  deletion  profiles  were  analysed  as  separate  alleles,  the  EHH  pattern  
291 was  similarly  low  for  chr13-P1,  P3  and  P4  ( Supplementary  Figure  10 ).  Comparison  
292 of  EHH  around  the  pfhrp3 -intact  and  P3-like  pfhrp3  deletions  using  WGS  data  from  
293 the  25  MalariaGEN  samples  confirmed  our  finding  that  the  EHH  quickly  decreased  
294 for  both  pfhrp3- intact  and  pfhrp3- deletion  alleles  ( Supplementary  Figure  9B ).  Taken  
295 together,  these  findings  suggest  that  each  pfhrp3  deletion  profile  arose  multiple  times  
296 independently,  and/or  they  have  been  present  in  the  parasite  population  for  sufficient  
297 time  for  homozygosity  due  to  genetic  hitchhiking  to  be  degraded  by  recombination  
298 with  different  haplotypes.  
299   
300 DISCUSSION  
301 Using  the  largest  prospective  study  of  pfhrp2/3- deleted  P.  falciparum  
302 performed  to-date  and  complementary  molecular,  immunological,  and  novel  
303 sequencing  assays,  we  provide  clear  evidence  that  pfhrp2/3- deleted  parasites  are  
13  
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304 circulating  in  multiple  sites  along  Ethiopia’s  borders  with  Sudan  and  Eritrea.  Analysis  
305 of  flanking  haplotypes  suggests  that  the  pfhrp2  deletion  mutation  emerged  and  
306 recently  expanded  from  a  single  origin,  while  pfhrp3  deletion  mutations  have  existed  
307 for  a  longer  time  span  and  likely  have  multiple  origins.  As  expected,  we  did  not  
308 observe  perfect  concordance  between  RDT  results,  PCR,  a  bead-based  
309 immunoassay,  WGS,  and  MIP  sequencing  results.  However,  the  preponderance  of  
310 evidence  from  these  diverse  platforms  provides  robust  confirmation  of  deletions  and  
311 supports  the  use  of  World  Health  Organization  (WHO)  protocols  for  rapid  pfhrp2/3  
312 deletion  surveillance. 29    The  prevalence  of  false-negative  HRP2-based  RDT  results  
313 due  to  pfhrp2  deletions  is  estimated  at  9.7%  overall  and  up  to  11.5%  and  14.9%  in  
314 the  Amhara  and  Tigray  regions,  respectively.  These  estimates  exceed  WHO  
315 minimum  criteria  (>5%)  for  a  change  in  national  diagnostic  testing  strategy.  
316 Pfhrp2/3- deleted  parasites  threaten  recent  progress  made  by  Ethiopia’s  malaria  
317 control  and  elimination  program,  and  raise  concerns  about  ongoing  use  of  and  
318 exclusive  reliance  on  HRP2-based  RDTs  in  the  region  for  diagnosis  of  falciparum  
319 malaria.  
320 Eritrea’s  alarming  reports  of  false-negative  RDTs  due  to  pfhrp2/3- deleted  
321 parasites  prompted  an  immediate  change  in  national  diagnostic  testing  policy  in  
322 2016 15,36 .  Recent  evidence  from  Sudan,  Djbouti,  and  Somalia  suggests  that  the  Horn  
323 of  Africa  may  already  be  heavily  affected  by  pfhrp2/3- deleted  parasites 37,38 ,  though  
324 results  from  ongoing  surveillance  efforts  are  not  yet  publicly  available.  Within  
325 affected  regions  in  Ethiopia,  we  observed  spatial  heterogeneity  in  P.  falciparum  RDT  
326 profiles  by  district,  with  prevalence  of  the  discordant  HRP2-,  PfLDH+  RDT  profile  
327 ranging  from  0.9  to  30%  ( Supplementary  Table  2 ).  While  finer  scale  spatial  
14  
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328 analyses  were  not  possible  due  to  our  health  facility  sampling  approach,  this  finding  
329 is  consistent  with  prior  studies  showing  variation  within  countries  and  by  region 25 .  
330 Differences  in  transmission  intensity,  treatment-seeking  behavior,  diagnostic  testing  
331 capacity,  and  seasonality  may  account  for  some  of  the  spatial  variation  in  pfhrp2/3  
332 deletion  prevalence  estimates 17,39–41 .  Although  the  factors  driving  emergence  of  these  
333 parasites  in  some  regions  but  not  others  remain  poorly  understood,  our  study  
334 suggests  that  pfhrp2- deleted  parasites  may  have  spread  widely  within  Ethiopia  from  
335 a  single  origin.  This  finding  is  consistent  with  early  microsatellite  analysis  of  
336 pfhrp2/3- deleted  strains  in  Eritrea,  in  which  30  of  31  (96.8%)  pfhrp2- deleted  strains  
337 fell  into  a  single  genetically  related  cluster, 15   and  raises  concern  about  clonal  
338 expansion  of  pfhrp2- deleted  strains  in  the  Horn  of  Africa.  
339 Using  a  multi-faceted  approach,  we  validate  the  use  of  MIP  sequencing  for  
340 high-throughput  pfhrp2/3  deletion  genotyping,  deletion  profiling,  and  population  
341 genetic  analysis.  Comparison  of  MIP  sequencing  to  other  approaches  demonstrated  
342 that  it  can  be  used  for  cost-effective  (approximately  $10-15  per  sample)  and  scalable  
343 deletion  genotyping  in  samples  with  parasite  densities  of  approximately  1,000  
344 parasites/µL.  While  this  threshold  can  likely  be  improved  by  additional  sequencing  of  
345 samples  with  inadequate  sequencing  depth-of-coverage,  in  this  case,  the  equivalent  
346 of  half  a  NextSeq  550  flow  cell  enabled  visualization  of  deletion  breakpoint  regions  
347 and  variant  calling  in  P.  falciparum’ s  subtelomeres  in  a  large  portion  of  samples, 
348 without  the  need  for  costly  enrichment  and  WGS.   
349 Based  on  analysis  of  MIP  sequencing  and  available  WGS  data,  we  posit  one 
350 potential  model  by  which  pfhrp2/3- deleted  parasite  populations  may  have  evolved  in  
351 the  Horn  of  Africa.  Findings  from  this  study  suggest  that  parasite  populations  with  
15  
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352 pfhrp3  deletions  expanded  in  the  more  distant  past  and  potentially  arose  multiple  
353 times  independently,  based  on  low  EHH  surrounding  pfhrp3,  multiple  deletion  profile  
354 patterns,  the  high  overall  frequency  of  pfhrp3- deleted  parasites,  and  their  presence  
355 in  older  samples  from  2013  in  the  MalariaGEN  study.  In  this  milieu,  recent  strong  
356 selection  favoring  parasites  with  deletions  of  pfhrp2  likely  occurred  due  to  
357 “test-track-treat”  policies  that  rely  upon  HRP2-based  RDTs  and  allow  parasites  with  
358 deletions  of  both  genes,  or  in  some  cases  one  of  the  two  genes,  to  escape  
359 treatment.  Implicit  in  this  model  is  the  assumption  that  forces  apart  from  RDT-derived  
360 pressure  are  also  driving  the  evolution  of  pfhrp2/3  deletions.  First,  test-track-treat  
361 policies  do  not  explain  the  prevalence  and  genetic  evidence  of  well-established  
362 pfhrp3  deletions  in  Ethiopia,  as  malaria  due  to  pfhrp2+/3-  parasites  should  be  
363 detectable  by  HRP2-based  RDTs 42 .  Second,  pfhrp2/3- deleted  parasites  are  highly  
364 prevalent  in  South  America, 25   where  RDT-based  treatment  decisions  have  never  
365 been  common.  Third,  the  prevalence  of  pfhrp2/3- deleted  parasites  appears  to  have  
366 remained  stable  in  Eritrea  despite  removal  of  HRP2-based  RDTs  two  years  ago. 38    
367 What  other  advantages  might  pfhrp2/3- deleted  parasites  have  over  those  with  
368 intact  genes?  Our  limited  understanding  of  the  biology  of  these  deletions  makes  this  
369 question  hard  to  answer.  Several  lines  of  inquiry  may  be  relevant:  1)  They  may  be  
370 better  adapted  to  low  transmission  intensity  settings  than  other  strains.  
371 Pfhrp2/3- deleted  parasites  appear  to  be  more  common  in  regions  with  lower  
372 transmission  and,  presumably,  lower  complexities  of  infection. 40   This  trend  might  
373 simply  be  an  artifact  of  the  assays  used  to  detect  them  -  i.e.,  neither  PCR,  antigen  
374 immunoassays,  nor  common  sequencing  methodologies  are  well  suited  to  detect  a  
375 pfhrp2/3- deleted  strain  when  pfhrp2/3- intact  strains  have  co-infected  a  human  host.  
16  
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376 The  high  frequency  of  monoclonal  samples  in  our  MIP  sequence  analysis  provides  
377 support  for  this  hypothesis.  However,  it  is  also  possible  that  the  pfhrp2/3  genes  are  
378 an  asset  when  within-host  competition  is  common  but  a  liability  when  it  is  rare.  This  
379 makes  sense  if  parasites  in  low-transmission  settings  gain  an  advantage  through  
380 improved  gametocytogenesis  and  transmission,  for  example.  2)  Loss  of  pfhrp2/3  or  
381 flanking  genes  may  alter  parasite  virulence.  Evidence  is  accumulating  that  HRP2  
382 plays  a  role  in  cerebral  malaria  and  endothelial  inflammation  during  severe  
383 malaria 43,44 .  People  infected  by  pfhrp2/3- deleted  parasites  may  have  less  severe  
384 disease  and  therefore  be  less  likely  to  seek  treatment,  increasing  the  likelihood  of  
385 onward  transmission.  However,  we  cannot  exclude  the  possibility  that  pfhrp2/3  are  
386 lost  as  a  consequence  of  selection  on  other  genes.  For  example,  the  flanking  gene  
387 EBL-1  is  almost  uniformly  lost  in  pfhrp3- deleted  parasites  in  this  cohort  and  appears  
388 to  play  a  role  during  invasion  of  red  blood  cells 34,45 .  Similarly,  members  of  the  rifin  
389 and  stevor  gene  families  with  potential  roles  in  parasite  virulence  were  lost  in  the  
390 subtelomeric  deletions  observed  in  this  study 46,47 .  We  did  not  observe  evidence  of  an  
391 association  between  virulence  and  subtelomeric  deletions  in  our  cohort,  but  limited  
392 clinical  data  prevents  us  from  assessing  the  hypothesis  rigorously.  3)  Loss  of  
393 pfhrp2/3  or  flanking  genes  may  improve  transmissibility  to  or  from  mosquitoes.  To  
394 our  knowledge,  this  phenomenon  has  not  been  studied.  These  and  other  hypotheses  
395 require  experimental  and  improved  epidemiological  analyses.  Regardless  of  the  
396 evolutionary  forces  at  play,  our  findings  strongly  suggest  that  the  evolution  of  
397 pfhrp2/3- deleted  parasites  in  Ethiopia  was  a  multi-step  process  that  involved  earlier  
398 expansion  of  pfhrp3-  than  pfhrp2- deleted  parasite  populations.  
399 This  study  has  several  limitations.  First,  the  study  design  prioritized  evaluation  
17  
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400 of  samples  with  discordant  RDT  results  (HRP2-  but  Pf-LDH+)  for  rapid  assessment  
401 of  false-negative  RDTs  due  to  pfhrp2/3  deletions  in  the  context  of  clinical  treatment.  
402 This  feature  of  the  WHO  protocol  is  intentional  as  it  captures  clinically  significant  
403 pfhrp2/3  deletions  and  enables  real-time,  efficient  signaling  to  malaria  control  
404 programs  of  a  potential  problem,  but  it  also  introduces  selection  bias  that  requires  
405 careful  consideration  when  estimating  the  true  prevalence  of  pfhrp2/3- deleted  
406 parasites.  We  overcame  this  limitation  by  using  a  conservative  approach  that  
407 incorporated  both  RDT  and  PCR  data  to  estimate  false-negative  RDT  results  due  to  
408 pfhrp2  deletions.  This  metric  is  relevant  to  control  programs,  but  does  not  capture  
409 asymptomatic  or  low-parasite-density  infections  by  pfhrp2/3- deleted  parasites.  
410 Second,  only  a  subset  of  samples  underwent  advanced  analysis,  and  clinical  data  
411 was  not  available  for  all  subjects.  This  was  not  unexpected  for  a  pragmatic  field  
412 study  of  this  size.  We  do  not  believe  that  it  introduced  sufficient  bias  into  our  
413 prevalence  estimates  or  population  genetic  analysis  to  change  our  conclusions.  
414 Third,  we  cannot  comment  on  changes  in  selection  pressure  over  time  because  the  
415 study  was  cross-sectional.  Fourth,  we  only  sampled  three  regions  of  Ethiopia,  which  
416 is  a  diverse  and  populous  country.  In  response,  the  Federal  Ministry  of  Health  is  now  
417 conducting  a  country-wide  survey  that  will  enable  comparison  of  pfhrp2/3  deletions  
418 over  time  in  select  sites.  
419   
420 CONCLUSION  
421 Leveraging  a  large  prospective  study,  established  molecular  and  antigen  
422 detection  methods,  and  a  novel  targeted  sequencing  approach,  we  demonstrate  that  
423 pfhrp2/3- deleted  P.  falciparum  is  a  common  cause  of  false-negative  RDT  results  
18  
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424 among  subjects  presenting  with  symptomatic  malaria  in  three  regions  of  Ethiopia.  
425 The  genomic  tools  employed  in  this  study  reveal  complex  origins  of  these  parasites.  
426 Recent,  strong  selective  pressures  favoring  pfhrp2- deleted  parasites  appear  to  have  
427 occurred  on  a  background  of  pre-existing  pfhrp3  deletions.  Existing  malaria  control  
428 programs  in  the  region  are  threatened  by  expansion  of  these  parasite  strains,  and  
429 surveillance  is  urgently  needed  to  inform  decisions  about  when  alternative  malaria  
430 diagnostics  should  be  deployed.   
431   
432 METHODS  
433 Study  Design  and  Data  Collection  
434 We  performed  a  cross-sectional,  multi-site  study  in  eleven  districts  along  
435 Ethiopia’s  borders  with  Eritrea,  Sudan,  and  South  Sudan,  located  within  three  of  its  
436 nine  administrative  regions.  On  average,  ten  health  facilities  were  selected  from  
437 each  district,  including  four  districts  of  Amhara  Region  (northwest  Ethiopia),  six  
438 districts  of  Tigray  Region  (north  Ethiopia),  and  one  district  of  Gambella  Region  
439 (southwest  Ethiopia)  during  the  2017-2018  peak  malaria  transmission  season  
440 (September-December)  (see  Figure  1 ).  Per  WHO  protocol 29 ,  each  facility  passively  
441 enrolled  participants  presenting  with  symptoms  of  malaria  (fever,  headache,  joint  
442 pain,  feeling  cold,  nausea,  and/or  poor  appetite),  with  sample  size  proportionally  
443 allocated  to  each  facility  based  on  the  previous  year’s  malaria  case  load.  All  
444 participants  provided  informed  consent,  participated  in  interview  questionnaires,  and  
445 underwent  blood  collection  for  RDT  testing  using  two  types  of  RDTs.  Ethical  approval  
446 was  obtained  from  the  Ethiopia  Public  Health  Institute  (EPHI)  Institutional  Review  
447 Board  (IRB;  protocol  EPHI-IRB-033-2017)  and  WHO  Research  Ethics  Review 
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448 Committee  (protocol:  ERC.0003174  001).  Processing  of  de-identified  samples  and  
449 data  at  UNC  was  determined  to  constitute  non-human  subjects  research  by  the  UNC  
450 IRB  (study  17-0155).  The  study  was  determined  to  be  non-research  by  the  Centers  
451 for  Disease  Control  and  Prevention  Human  Subjects  office  (0900f3eb81bb60b9).  
452 Experiments  were  performed  in  accordance  with  relevant  guidelines  and  regulations.  
453    
454 Field  Sample  Evaluation  
455 Study  participants  were  evaluated  using  both  a  CareStart  Pf/Pv  
456 (HRP2/Pv-pLDH)  RDT  (Access  Bio,  Somerset,  NJ;  product  code  RM  VM-02571)  and  
457 an  SD  Bioline  Malaria  Ag  P.f.  (HRP2/Pf-LDH)  RDT  (Alere,  Waltham,  MA;  product  
458 0code  05FK90).  For  the  CareStart  RDT,  5  µL  of  capillary  whole  blood  was  collected  
459 by  finger  prick  and  transferred  to  the  RDT  sample  well,  along  with  60  µL  of  buffer  
460 solution.  Results  were  read  at  20  minutes.  The  SD  Bioline  RDT  followed  the  same  
461 protocol,  but  with  4  drops  of  buffer  added  and  results  read  in  a  15-30  minute  window.  
462 Participants  testing  positive  by  either  RDT  were  first  prescribed  treatment,  according  
463 to  Ethiopian  national  guidelines. 48    
464 Cases  with  any  positive  HRP2  or  Pf-LDH  RDT  band  were  considered  positive  
465 for  P.  falciparum  malaria.  Cases  Pf-LDH-positive  but  HRP2-negative  on  both  RDTs  
466 were  considered  potential  candidates  for  pfhrp2/3  gene  deletion  and  defined  as  
467 ‘discordant.’  These  participants,  along  with  a  subset  of  HRP2-positive  and  -negative  
468 controls,  provided  further  informed  consent  for  additional  blood  collection  for  dried  
469 blood  spot  (DBS)  preparation.  At  least  two  DBS  samples  (50  µL/spot)  were  collected  
470 on  Whatmann  903  protein  saver  cards  (GE  Healthcare,  Chicago,  IL)  from  consenting  
471 participants.  DBS  were  stored  in  plastic  bags  with  desiccant.  A  randomly  selected  
20  
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472 subset  of  DBS  were  sent  for  molecular  analysis  to  the  University  of  North  Carolina  at  
473 Chapel  Hill  and  for  serological  analysis  to  the  Centers  for  Disease  Control  and  
474 Prevention  (CDC,  Atlanta,  GA). 
475   
476 DNA  Extraction  and  PCR  assays  
477 DNA  was  extracted  from  three  6mm  punches  per  DBS  sample  using  
478 Chelex-100  and  saponin  as  previously  described 49 .  Quantitative  PCR  (qPCR)  assays  
479 were  first  performed  in  duplicate  for  pfldh 50 .  To  avoid  the  risk  of  misclassification  due  
480 to  DNA  concentrations  below  the  limit  of  detection  for  pfhrp2/3  PCR  assays,  further  
481 analysis  was  restricted  to  samples  with  >100  parasites/µL  by  qPCR  
482 ( Supplementary  Figure  2 ). 14   PCR  assays  targeting  exon  2  of  pfhrp2  and  pfhrp3  
483 were  then  performed  in  duplicate  as  previously  described, 7   except  that  PCRs  were  
484 performed  as  single-step,  45-cycle  assays,  using  10µL  template  and  AmpliTaq  Gold  
485 360  Master  Mix  (Thermo  Fisher  Scientific,  Waltham,  MA)  in  25  µL  reaction  volume.  
486 In  addition  to  no-template  and  P.  falciparum  3D7  strain  ( pfhrp2+/3+ )  positive  controls,  
487 pfhrp2  assays  included  an  additional  DD2  strain  ( pfhrp2-/3+ )  control  and  pfhrp3  
488 assays  included  an  additional  HB3  strain  ( pfhrp2+/3- )  control.  Finally,  an  additional  
489 single-copy  gene,  real-time  PCR  assay  targeting  P.  falciparum  beta-tubulin  was  
490 performed  to  confirm  that  sufficient  parasite  DNA  remained  in  samples  with  a  
491 negative  pfhrp2/3  PCR  result. 14   Pfhrp2/3  genotyping  calls  were  made  in  samples  
492 with  pfldh  qPCR  parasitemia  >100  parasites/µL  to  avoid  misclassification  in  the  
493 setting  of  amplification  failure  due  to  low  target  DNA  concentration.  A  pfhrp2  or  
494 pfhrp3  positive  call  required  ≥1  replicate  with  distinct  band(s)  with  expected  fragment  
495 length.  A  negative  call  required  both  pfhrp2  or  pfhrp3  replicates  to  be  negative.  
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496 Detailed  reaction  conditions  for  all  PCR  assays  are  described  in  the  Supplementary  
497 File .  
498   
499 Serological  assays  
500 The  presence  of  HRP2,  pan-LDH,  and  aldolase  antigenemia  was  assessed  in  
501 a  subset  of  DBS  samples  (single  6mm  punch)  using  a  multiplex  bead-based  
502 immunoassay  as  previously  described 13 .  Within  this  multiplex  assay,  capture  and  
503 detection  antibodies  against  the  HRP2  antigen  would  also  recognize  similar  epitopes  
504 on  the  HRP3  antigen,  so  unique  signals  for  these  two  antigens  cannot  be  obtained.   
505   
506 Prevalence  estimates  
507 We  estimated  the  prevalence  of  P.  falciparum  infections  expected  to  have  
508 false-negative  HRP2-based  RDT  results  due  to  pfhrp2  deletions  as  follows.  First,  we  
509 calculated  the  proportion  of  all  RDT-positive  P.  falciparum  cases  (HRP2+  or  PfLDH+  
510 on  any  RDT)  with  the  discordant  RDT  profile  (HRP2-  on  both  RDTs,  but  PfLDH+),  
511 overall  and  by  region.  Second,  we  calculated  the  observed  concordance  between  
512 the  discordant  RDT  profile  and  a  pfhrp2- negative  PCR  call,  overall.  Prevalence  
513 estimates  and  95%  CIs  were  then  back-transformed  overall  and  by  region  using  the  
514 ci.impt  function  within  the  asbio  R  package,  which  generates  CIs  for  the  product  of  
515 two  proportions  using  delta  derivation.  This  allowed  us  to  estimate  with  confidence  
516 the  proportion  of  P.  falciparum  infections  with  both  pfhrp2  deletions  and  
517 false-negative  HRP2-based  RDT  results,  overall  and  by  region.  As  a  sensitivity  
518 analysis,  we  also  estimated  the  proportion  of  those  with  a  discordant  RDT  and  a  
519 pfhrp2- negative  PCR  call  (directly  multiplying  the  true  proportion  of  Pf-positive  
22  
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520 individuals  with  a  discordant  RDT  profile,  overall  and  by  region,  by  0.727,  or  the  
521 overall  proportion  of  discordant  RDT  samples  that  had  a  pfhrp2-  PCR  result).  95%  
522 CIs  were  then  generated  using  bootstrapping  (1000  iterations).  The  prevalence  
523 estimates  and  CIs  generated  by  the  two  approaches  were  similar  (Supplementary  
524 Table  3) .  
525   
526 Pfhrp2/3  molecular  inversion  probe  (MIP)  development  
527 Pfhrp2,  pfhrp3,  and  the  flanking  regions  within  a  100kb  window  surrounding  
528 each  gene  were  targeted  for  MIP  designs  using  MIPTools 51 .  A  tiled  design  strategy  
529 was  employed  that  involved  multiple,  overlapping  probes  spanning  each  gene  target.  
530 22  genes  flanking  pfhrp2  and  31  genes  flanking  pfhrp3  were  used  in  the  design,  of  
531 which  11  and  19  were  successful  on  the  first  design  try,  respectively.  A  second  
532 attempt  was  not  made  for  designs  for  the  flanking  genes.  A  total  of  241  probes;  9  for  
533 pfhrp2 ,  9  for  pfhrp3  and  223  probes  for  the  flanking  genes  were  designed.  MIPs  
534 were  designed  using  the  3D7  (v3)  reference  genome  avoiding  hybridization  arms  in  
535 variant  regions  when  possible.  80  alternative  probes  accommodating  potential  
536 variants  in  the  highly  variable  pfhrp2  and  pfhrp3  genes  were  also  created.  A  15.5  kb  
537 segment  centromeric  to  pfhrp3  on  chromosome  13  between  positions  
538 2792000-2807500  is  duplicated  on  chromosome  11  between  positions  
539 1918007-1933488,  with  99.4%  sequence  identity.  Therefore,  the  target  genes  falling  
540 into  this  region  were  multicopy  genes  and  their  probes  were  designed  to  bind  to  both  
541 loci  on  the  genome  (see  Supplementary  Table  5  for  the  design  overview  including  
542 all  genes  targeted,  MIPs  designed  and  genomic  coordinates).  Probes  were  ordered  
543 from  Integrated  DNA  Technologies  (Coralville,  Indiana,  USA)  as  200  pmol  ultramer  
23  
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544 oligos.  Probe  sequences  are  provided  in  the  Supplementary  Table  6.  
545   
546 MIP  capture  and  deep  sequencing  of  clinical  samples  
547 All  DNA  samples  extracted  by  UNC  underwent  MIP  capture  using  the  capture  
548 and  amplification  methods  exactly  as  described  by  Verity  et  al . 52 ,  with  the  exception  
549 of  oligonucleotides  (the  pfhrp2/3  MIP  oligonucleotide  panel  described  above  was  
550 used)  and  controls  (we  selected  a  different  set  of  controls  that  are  informative  for  
551 pfhrp2/3  deletion  characterization).  All  MIP  captures  included  multiple  controls:  3D7  
552 ( pfhrp2+/3+ ),  DD2  ( pfhrp2-/3+ ),  HB3  ( pfhrp2+/3- )  laboratory  strains;  as  well  as  LC  
553 and  HC  mixes  (1%  HB3,  10%  DD2,  89%  3D7)  at  250  and  1000  parasites/µl  
554 densities,  respectively.  Samples  were  sequenced  on  the  Illumina  NextSeq  550  
555 instrument  using  150bp  paired-end  sequencing  and  dual  indexing.  
556   
557 Subtelomeric  profiling  and  variant  calling  with  MIP  data  
558 Read  mapping  and  variant  calling  were  carried  out  using  MIPTools  
559 (v0.19.12.13) 51 .  MIPTools  uses  the  MIPWrangler  algorithm  (v1.2.0) 53   to  create  high  
560 quality  consensus  sequences  from  sequence  read  data  utilizing  unique  molecular  
561 indexes  (UMIs)  of  MIPs,  maps  those  sequences  to  the  reference  genome  using  bwa  
562 (v0.7.17)  and  remove  off  target  sequences  as  described  previously 31,52 .  Deletion  calls  
563 were  limited  to  the  samples  that  had  high  coverage  to  avoid  false  positives.  
564 Considering  the  high  frequency  of  large  deletions  present  in  the  sample  set,  the  
565 coverage  threshold  was  based  on  a  subset  of  probes  that  were  present  on  >  60%  of  
566 the  samples,  none  of  which  overlapped  with  the  chromosome  8  or  13  deletions.  
567 Samples  with  a  median  coverage  of  <  5  UMIs  for  this  subset  of  probes  were  
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568 excluded  from  analysis.  
569 Structural  profiling  was  performed  using  the  UMI  count  table  ( Supplementary  
570 Table  7 ).  The  count  table  was  converted  to  a  presence/absence  table  such  that  if  a  
571 probe  had  >  1  UMI  for  a  given  sample,  it  was  accepted  as  present  (i.e.,  not  deleted).  
572 Samples  were  clustered  into  subtelomeric  structural  profile  groups  based  on  this  
573 table  using  the  hierarchical  clustering  algorithm  AgglomerativeClustering  of  the  
574 Python  module  Scikit-learn  (v0.20) 54   using  only  the  regions  involved  in  the  deletion 
575 events  of  the  corresponding  chromosome  (position  >  1372615  for  chromosome  8  
576 and  position  >  2806319  for  chromosome  13).  Samples  were  grouped  into  their  final  
577 subtelomeric  structural  profile  based  on  visual  inspection  of  the  resulting  clusters.  
578 Initial  variant  calls  were  made  using  freebayes  (v1.3.1)  via  MIPTools  with  the  
579 following  options:  --pooled-continuous  --min-base-quality  1  --min-alternate-fraction  
580 0.01  --min-alternate-count  2  --haplotype-length  -1  --min-alternate-total  10  
581 --use-best-n-alleles  70  --genotype-qualities.  Variants  were  processed  using  MIPTools  
582 to  filter  for:  variant  quality  >  1,  genotype  quality  >  1,  average  alternate  allele  quality  >  
583 15,  minimum  depth  >  2  UMIs;  and  make  final  genotype  calls  based  on  the  major  
584 allele  (within  sample  allele  frequency  >  0.5).  In  addition,  the  following  variants  were  
585 removed  from  the  final  call  set:  those  that  were  observed  as  a  major  allele  in  less  
586 than  two  samples  (singletons),  not  supported  by  more  than  two  UMIs  in  at  least  three  
587 samples,  present  on  multicopy  genes,  and  indels.  Variant  calls  were  further  filtered  
588 for  missingness  to  avoid  imputation  in  EHH  calculations:  samples  missing  calls  for  
589 >50%  of  the  variants  were  removed,  variants  missing  calls  in  >50%  of  the  samples  
590 were  removed.  Variants  calls  were  converted  to  .map  and  .hap  files  ( Supplementary  
591 Table  8 )  for  use  with  the  rehh  package  in  R.  
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592   
593 Assessment  of  MIP  calls  using  whole-genome  sequencing  
594 We  performed  WGS  on  a  subset  of  samples  to  assess  the  accuracy  of  MIP  
595 pfhrp2/3  deletion  calls.  DNA  extracted  from  samples  with  discordant  RDT  results  
596 were  selected  for  P.  falciparum  selective  whole-genome  amplification  (sWGA)  and  
597 whole-genome  sequencing  as  described  previously 30 .  In  brief,  DNA  was  first  
598 subjected  to  two  separate  sWGA  reactions  using  the  Probe_10  primer  set  described  
599 by  Oyola  et  al. 55   and  the  JP9  primer  set. 30   sWGA  products  were  then  pooled  in  equal  
600 volumes  and  acoustically  sheared  using  a  Covaris  E220  instrument  prior  to  
601 sequencing  library  preparation  using  Kappa  Hyper  library  preps.  Indexed  libraries  
602 were  then  pooled  and  sequenced  on  an  Illumina  HiSeq  4000  instrument  using  
603 150bp,  paired-end  sequencing.  Sequencing  reads  were  deposited  into  NCBI’s  
604 Sequence  Read  Archive  (accession  numbers  pending).  
605   
606 Published  whole  genome  sequencing  data  retrieval  
607 Fastq  files  from  25  Ethiopian  samples  included  in  the  MalariaGEN  genome  
608 variation  project 19   and  3  laboratory  strains  (3D7,  HB3  and  DD2)  from  MalariaGEN  
609 genetic  crosses  project 56   were  downloaded  from  the  European  Nucleotide  Archive  
610 using  fasterq-dump  (v2.10.8)  and  sample  accession  numbers  ( Supplementary  
611 Table  9 ).  
612   
613 WGS  data  analysis  
614 All  fastq  files  were  processed  as  follows.  Adapter  and  quality  trimming  was  
615 performed  using  Trimmomatic  (v.0.39)  with  the  recommended  options  (seed  
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616 mismatches:2,  palindrome  clip  threshold:30,  simple  clip  threshold:10,  
617 minAdapterLength:2,  keepBothReads  LEADING:3  TRAILING:3  MINLEN:36).  
618 Trimmed  fastq  files  were  mapped  to  3D7  reference  genome  (v3.0)  concatenated  to  
619 human  genome  (hg38)  to  avoid  incorrect  mapping  of  reads  originating  from  host  
620 DNA  using  bowtie2  (v2.3.0)  with  the  ‘--very-sensitive’  option.  Reads  mapping  to  the  
621 parasite  chromosomes  were  selected  and  optical  duplicates  were  removed  using  the  
622 sambamba  (v0.7.1)  view  and  markdup  commands,  respectively.  Read  coverage  was  
623 calculated  using  samtools  (v1.9)  depth  command  with  options  ‘-a  -Q1  -d0’,  filtering  
624 reads  with  mapping  quality  of  zero.  Variants  were  called  only  for  the  regions  of  
625 interest  using  freebayes  (v1.3.1)  with  the  following  options:  ‘--use-best-n-alleles  70  
626 --pooled-continuous  --min-alternate-fraction  0.01  --min-alternate-count  2  
627 --min-alternate-total  10  --genotype-qualities  --haplotype-length  -1  
628 --min-mapping-quality  15  -r  region’.  Regions  of  interest  were  from  300  kb  
629 centromeric  to  the  deletions  to  chromosome  ends  (positions  1074000-1472805  and  
630 2505000-2925236  for  chromosomes  8  and  13,  respectively).  
631 Variants  were  filtered  for:  variant  quality  >  20,  genotype  quality  >  15,  average  
632 alternate  allele  quality  >  15,  minimum  depth  >  4  reads.  In  addition,  the  following  
633 variants  were  removed  from  the  final  call  set:  those  that  were  never  observed  as  a  
634 major  allele  in  any  sample,  not  supported  by  more  than  10  reads  in  at  least  one  
635 sample,  and  indels.  Final  genotype  calls  were  based  on  the  major  allele  (within  
636 sample  allele  frequency  >  0.5).  Variant  calls  were  further  filtered  for  missingness  to  
637 avoid  imputation  in  EHH  calculations:  samples  missing  calls  for  >95%  of  the  variants  
638 were  removed,  variants  missing  calls  in  >10%  of  the  samples  were  removed.  
639 Telomeric  profiling  of  the  published  genomes  was  carried  out  by  visual  inspection  of  
27  
  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250503doi: medRxiv preprint 
  
640 depth-of-coverage  plots  ( Supplementary  Figures  8  and  9 ).  Summary  statistics  were  
641 generated  ( Supplementary  Table  10 )  using  the  python  pandas  module  (v0.23).   
642   
643 Statistical  and  population  genetic  analysis  
644 Data  collected  during  the  participant’s  study  visit  (clinical  data  and  RDT  
645 results)  was  linked  to  laboratory  results  via  the  barcode  number  transcribed  on  DBS  
646 sent  to  the  UNC  and  CDC  laboratories.  Samples  in  the  dataset  with  missing  or  
647 duplicate  barcodes  were  arbitrated  using  original  paper  questionnaires  by  the  EPHI  
648 data  center.  Ultimately,  an  analysis  dataset  that  included  both  PCR  and  field  data  
649 was  created  including  all  samples  we  could  confidently  merge  by  both  barcode  
650 number  and  region  label.   
651 Statistical  analysis  was  performed  using  R  (version  3.6.0,  R  Core  Team,  
652 Vienna,  Austria,  2019;  www.R-project.org).  ArcGIS  (Desktop  Version  10.5,  ESRI,  
653 Redlands,  CA,  2016)  was  utilized  for  mapping,  with  additional  annotation  performed  
654 using  PowerPoint  (version  16.31,  Microsoft,  Redmond,  WA,  2019).   
655 Extended  haplotype  homozygosity  (EHH)  statistics  were  calculated  to  
656 evaluate  the  regions  flanking  the  pfhrp2  and  pfhrp3  genes  for  signatures  of  recent  
657 positive  selection 35   using  the  rehh  package  (version  3.1.2) 57 .  EHH  statistics  were  
658 calculated  using  the  data2haplohh  and  calc_ehh  functions,  haplotype  furcations  
659 were  calculated  using  calc_furcation,  and  plots  were  generated  using  the  package’s  
660 plot  function  and  annotated  using  Inkscape  (version  0.92).  
661 Complexity  of  infection  (COI)  for  each  sample  was  calculated  using  McCOILR  
662 (v1.3.0,  https://github.com/OJWatson/McCOILR ),  an  Rcpp  wrapper  for  THE  REAL  
663 McCOIL 58   with  the  options  maxCOI=25,  totalrun=2000,  burnin=500,   M0=15,  
28  
  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250503doi: medRxiv preprint 
  
664 err_method=3.  The  same  variant  set  used  in  the  EHH  analysis  was  used  for  the  COI  
665 calculations,  except  that  variants  whose  within-sample  allele  frequency  were  
666 between  0.05  and  0.95  were  called  heterozygote  for  COI  analysis.    
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708 TABLES  
709   
710 Table  1.  Characteristics  of  study  subjects  and  RDT  results.  Abbreviations:  SD,  
711 standard  deviation;  RDT,  rapid  diagnostic  test;  HRP2,  histidine-rich  protein  2;  
712 Pv-LDH,  P.  vivax  parasite  lactate  dehydrogenase;  Pf-LDH,  P.  falciparum  parasite  
713 lactate  dehydrogenase.  
714   
32  
  
  Amhara   Gambella   Tigray   Overall   
Subjects ,  n  3,879  2,335  6,357  12,572  
Age ,  median  years  
(IQR)  
20  (10-28)  12  (5-19)  21  (9-37)  19  (8-30)  
Female  sex ,  n  (%)  1,492  (38.5)  1,055  (45.2)  3,008  (47.3)  5,555  (44.2)  
Location ,  n  (%)          
Rural  2,350  (60.6)  923  (39.5)  4,445  (69.9)  7,718  (61.4)  
Urban  1,282  (33.0)  82  (3.5)  1,609  (25.3)  2,973  (23.6)  
Missing  247  (6.4)  1,330  (57.0)  303  (4.8)  1,881  (15.0)  
Fever ,  n  (%)  3,607  (93.0)  2,255  (96.6)  5,593  (88.0)  11,455  (91.1) 
CareStart  RDT ,  n  (%)          
HRP2+,  Pv-LDH+  59  (1.5)  509  (21.8)  25  (0.4)  593  (4.7)  
HRP2+  only  1,053  (27.1)  165  (7.1)  507  (8.0)  1,725  (13.7)  
Pv-LDH+  only  241  (6.2)  11  (0.5)  338  (5.3)  590  (4.7)  
Negative  2,518  (64.9)  1,650  (70.7)  5,486  (86.3)  9,654  (76.8)  
Invalid  8  (0.2)  0  (0.0)  1  (0.0)  9  (0.1)  
SD-Bioline  RDT ,  n  (%)          
HRP2+,  Pf-LDH+  719  (18.5)  552  (23.6)  276  (4.3)  1,547  (12.3)  
HRP2+  only  297  (7.7)  106  (4.5)  201  (3.2)  604  (4.8)  
Pf-LDH+  only  239  (6.2)  11  (0.5)  168  (2.6)  418  (3.3)  
Negative  2,609  (67.3)  1,665  (71.3)  5,705  (89.7)  9,979  (79.4)  
Invalid  15  (0.4)  0  (0.0)  2  (0.0)  17  (0.1)  
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715   
716 Table  2.  Assay  results  across  platforms.  PCR,  bead-based  antigen  immunoassay,  
717 molecular  inversion  probe  (MIP)  deep  sequencing,  and  whole-genome  sequencing  
718 (WGS)  for  samples  P.  falciparum -positive  by  RDT  are  shown.  
719   
720   
721 *  Zero  median  WGS  coverage  across  1,000  base-pair  windows  encompassing  
722 pfhrp2  or  pfhrp3 ,  in  samples  with  clinical  data.  
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  RDT  results  
  2  HRP2+,  1  
PfLDH+  
2  HRP2-,  1  
PfLDH+  
1  HRP2+,  1  
HRP2-  
PCR  result,  n  379  176  47  
pfhrp2+/3+  210  (55%)  20  (11%)  19  (41%)  
pfhrp2-/3-  9  (2%)  114  (65%)  10  (22%)  
pfhrp2-/3+  7  (2%)  14  (8%)  5  (11%)  
pfhrp2+/3-  152  (40%)  28  (16%)  12  (26%)  
HRP2  immunoassay  
result,  n  
243  167  42  
HRP2+  224  (92%)  40  (24%)  30  (71%)  
HRP2-  19  (8%)  127  (76%)  12  (29%)  
MIP  result,  n  198  104  30  
pfhrp2+/3+  77  (39%)  5  (5%)  5  (17%)  
pfhrp2-/3-  10  (5%)  84  (81%)  10  (33%)  
pfhrp2-/3+  3  (2%)  1  (1%)  4  (13%)  
pfhrp2+/3-  108  (55%)  14  (13%)  11  (37%)  
WGS  result,  n*  0  22  0  
pfhrp2+/3+  NA  0  (0%)  NA  
pfhrp2-/3-  NA  22  (100%)  NA  
pfhrp2-/3+  NA  0  (0%)  NA  
pfhrp2+/3-  NA  0  (0%)  NA  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted January 29, 2021. ; https://doi.org/10.1101/2021.01.26.21250503doi: medRxiv preprint 
  
723 FIGURES  
724   
725   
726
727 Figure  1.  Distribution  of  P.  falciparum- positive  RDT  results  and  discordant  
728 profiles  suggestive  of  pfhrp2/3  gene  deletions.  A)  Aggregated  results  from  both  
729 RDTs,  CareStart  Pf/Pv  (HRP2/Pv-LDH)  RDT  and  SD  Bioline  Malaria  Ag  P.f.  
730 (HRP2/Pf-LDH)  RDT,  displayed  by  region  for  all  P.  falciparum  infections.  The  ‘2  
731 HRP2-,  1  Pf-LDH+’  discordant  RDT  profile  indicates  potential  infection  by  
732 pfhrp2/3- deleted  P.  falciparum.  Triangles  represent  the  enrollment  sites,  including  11  
733 districts  and  the  Kule  refugee  camp  within  the  Itang  district  in  Gambella.  B)  The  
734 percentage  of  study  participants  identified  with  P.  falciparum  infection  by  RDT  who  
735 had  the  discordant  RDT  profile,  by  district.    
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736   
737 Figure  2.  Deletion  profiling  using  MIP  sequencing  of  pfhrp2  (chromosome  8),  
738 pfhrp3  (chromosome  13),  and  flanking  regions  applied  to  375  field  samples .  
739 Samples  are  grouped  by  subtelomeric  structural  profile,  with  control  strains  denoted  
740 CT,  as  labeled  along  the  right  y-axis.  Columns  represent  each  MIP  target  segment,  
741 rows  represent  individual  samples,  and  the  color  scale  represents  log 10   unique  
742 molecular  identifier  (UMI)  depth-of-coverage  at  each  location.  Columns  are  labeled  
743 by  the  midpoint  of  each  probe’s  target  region.    
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744   
745 Figure  3.  Comparison  of  MIP  and  WGS  pfhrp2/3  deletion  calls  and  breakpoint  
746 regions.  Among  the  14  clinical  samples  subjected  to  both  methods,  each  sample  is  
747 represented  by  two  adjacent  rows  representing  WGS  (top)  and  MIP  (bottom)  
748 coverage  results.  WGS  coverage  is  displayed  as  the  log 10   median  number  of  aligned  
749 reads  per  1kb  window.  MIP  results  are  colored  by  whether  each  probe  captured  its  
750 target,  with  intervening  regions  not  targeted  in  the  MIP  panel  uncolored.  Sample  
751 numbers  (lab_ID)  are  provided  at  left.  The  locations  of  pfhrp2 ,  pfhrp3 ,  and  flanking  
752 genes  are  shown  in  black  with  non-genic  regions  in  gray.  
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753   
754   
755
  
756   
757 Figu re  4.  Extended  haplotype  homozygosity  (bottom)  and  the  bifurcation  
758 diagrams  showing  haplotype  branching  (top)  centromeric  to  the  pfhrp2  (A)  and  
759 pfhrp3  (B)  deletions  based  on  MIP  data .  Vertical  dashed  lines  indicate  the  
760 centromeric  end  of  deletions.  No  variant  calls  were  made  within  the  15.5  kb  region  
761 on  chromosome  13  which  is  duplicated  on  chromosome  11,  demarcated  by  the  gray  
762 box  (B).  Abbreviations:  Mb,  mega-base.  
763   
764    
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765 SUPPLEMENTARY  MATERIAL  
766   
767 Supplementary  Results  
768   
769 Association  between  malaria  symptoms,  geographical  location,  and  subtelomeric  
770 structural  variants  
771 We  did  not  observe  an  association  between  subtelomeric  deletion  profile  and  
772 the  number  of  symptoms  experienced  by  subjects  ( Supplementary  Figure  5 ).  
773 Because  the  majority  of  subjects  (96.5%,  2620/2714)  who  tested  positive  for  P.  
774 falciparum  by  RDT  were  febrile,  fever  alone  was  not  sufficient  to  evaluate  disease  
775 severity.  Therefore,  as  a  crude  metric  of  disease  severity,  we  calculated  the  total  
776 number  of  symptoms  (six  total  were  assessed:  fever,  headache,  joint  pain,  feeling  
777 cold,  nausea,  and  lack  of  appetite).  No  significant  differences  in  the  total  number  of  
778 symptoms  by  deletion  profile  were  revealed  for  chromosome  8  (one-way  ANOVA  p  =  
779 0.83)  or  chromosome  13  (p  =  0.72).  No  obvious  spatial  patterns  in  subtelomeric  
780 deletion  profiles  were  apparent  at  the  regional  level  ( Supplementary  Table  2 ).  
781   
782 Comparison  of  pfhrp2/3  PCR  and  HRP2  bead-based  assays  
783 We  observed  expected  agreement  between  the  results  of  pfhrp2/3  PCR  
784 assays,  RDTs,  and  a  bead-based  immunoassay  applied  to  a  subset  of  456  samples.  
785 93%  (95%  CI  86-96)  of  samples  pfhrp2+/3+  by  PCR  tested  positive  for  HRP2  
786 antigen  (GM  40,284  pg/mL  HRP2,  geoSD  7.5).  In  comparison,  19%  (12-29)  of  
787 pfhrp2-/3-  samples  were  HRP2+,  with  a  GM  of  2,089  pg/mL  HRP2  (geoSD  5.5).  
788 HRP2+  but  pfhrp2-  PCR  results  are  expected  in  a  subset  of  subjects  because  HRP2  
789 antigenemia  can  persist  for  weeks  after  clearance  of  parasitemia 32 .  92%  (95%  CI  
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790 88-95)  of  samples  HRP2+,  Pf-LDH+  by  RDT  were  HRP2+  by  the  antigen  assay  (GM  
791 34,536  pg/mL,  geoSD  6.5),  compared  to  24%  (95%  CI  18-31)  of  those  with  the  
792 discordant  HRP2-,  Pf-LDH+  RDT  profile  of  interest  (GM  2,455  pg/mL,  geoSD:  7.2)  
793 ( Table  2 ).   
794   
795 Subtelomeric  profiling  and  variant  calling  using  MIPs  
796 241  MIPs  mapped  to  273  targeted  loci  on  the  reference  genome,  including  32  
797 extra  loci  accounting  for  the  multicopy  genes  on  chromosome  11.  Probes  failing  to  
798 amplify  in  >90%  of  the  samples  were  removed  from  the  analysis,  leaving  244  loci.  
799 841  of  1014  samples  and  controls  had  sequence  data  after  read  mapping.  20  of  841  
800 belonged  to  control  strains  (positive  controls).  None  of  the  20  negative  controls  had  
801 any  sequence  mapping  to  the  reference  genome.  Deletion  calls  were  only  made  in  
802 samples  with  sufficient  depth  of  UMI  coverage  (see  Methods),  leaving  375  
803 high-coverage  samples  from  the  study  cohort  and  6  controls  in  the  final  call  set.   
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804 Supplementary  Files  
805 Supplementary  tables  are  compiled  into  a  single  file  for  ease  of  viewing.  
806   
807 Supplementary  Table  1.  PCR  results  by  age,  sex,  and  parasite  density.   
808 Supplementary  Table  2.  RDT  profile  by  district  for  individuals  P.  
809 falciparum -positive  by  RDT.  
810 Supplementary  Table  3.  Prevalence  estimate  sensitivity  analysis.  
811 Supplementary  Table  4.  MIP  subtelomeric  structural  profiles  by  region.  
812 Supplementary  Table  5.  Pfhrp2/3  MIP  panel  design  overview,  including  genes  
813 targeted,  MIPs  designed,  and  genomic  coordinates .  
814 Supplementary  Table  6.  Pfhrp2/3  MIP  panel  probe  sequences .  
815 Supplementary  Table  7 .  Absolute  (A)  and  normalized  (B)  unique  molecular  
816 identifier  (UMI)  counts  by  sample  and  locus.  
817 Supplementary  Table  8.  MIP  variant  calls,  which  were  converted  to  .map  and  
818 .hap  files.   
819 Supplementary  Table  9.  ENA  accession  numbers  of  previously  published  WGS  
820 data.  
821 Supplementary  Table  10.  Summary  statistics  of  WGS  coverage  for  samples  
822 sequenced  in  this  study.  
823 Supplementary  File.  PCR  reaction  conditions.   
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824 Supplementary  Figures  
825   
826 Supplementary  Figure  1.  Study  samples  and  assays  performed.  
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827   
828 Supplementary  Figure  2.  Parasite  density  distribution.  Pfldh  quantitative  PCR  
829 (qPCR)  results  used  to  assess  parasite  density  and  determine  which  samples  were  
830 eligible  for  pfhrp2/3  deletion  genotyping  using  a  series  of  PCR  assays.  Pfhrp2/3  
831 deletions  were  only  called  in  samples  with  >100  parasites/µL  (solid  line).   
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832   
833
  
834 Supplementary  Figure  3.  Pfhrp2  and  pfhrp3  PCR  results  by  RDT  profile.  A)  
835 Concordance  between  RDT  profile  and  PCR  pfhrp2/3  result  for  P.  falciparum  
836 samples  with  >100  parasites/µL.  B)  Pfhrp2/3  PCR  results  for  participants  with  the  
837 discordant  RDT  profile  and  sufficient  DNA  for  molecular  analysis  (n  =  176),  by  study  
838 region.    
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839   
840
  
841 Supplementary  Figure  4.  Successful  MIP  deletion  calls  versus  qPCR  parasite  
842 density.  Comparison  of  MIP  call  results  and  qPCR  parasite  densities  suggests  a  
843 project-specific  threshold  for  MIP  calling  of  approximately  925  p/µL  of  whole  blood  
844 (dashed  line).  
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846   
847 Supplementary  Figure  5.  Disease  severity  by  subtelomeric  structural  profile.  
848 Smoothed  distribution  of  disease  severity  for  each  of  the  broader  deletion  breakpoint  
849 haplotypes  along  chromosomes  8  (A)  and  13  (B)  identified  by  MIP  genomic  
850 enrichment.  The  total  number  of  symptoms  with  which  participants  presented  was  
851 used  to  estimate  disease  severity,  with  all  participants  evaluated  for:  fever,  
852 headache,  joint  pain,  feeling  cold,  nausea,  and  loss  of  appetite.  Profile  chr13-P2  was  
853 excluded  for  its  small  sample  size  (n=1).   
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855 Supplementary  Figure  6.  Chromosome  13  telomeric-end  coverage  (aligned  
856 reads/locus)  plot  of  WGS  control  strains  and  25  published  Ethiopian  genomes  
857 from  2013-2015  (MalariaGEN).  The  location  of  pfhrp3  is  indicated  by  vertical  red  
858 lines.  Inset  showing  pfhrp3  and  1  kilobase  flanking  genomic  region.  Large  
859 subtelomeric  deletions  containing  pfhrp3  are  apparent  in  the  laboratory  strain  HB3,  
860 as  well  as  11  samples  from  Ethiopia.   
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862 Supplementary  Figure  7.  Chromosome  8  telomeric-end  coverage   (aligned  
863 reads/locus)  plot  of  WGS  control  strains  and  25  published  Ethiopian  genomes  
864 from  2013-2015  (MalariaGEN).  The  location  of  pfhrp2  is  indicated  by  vertical  red  
865 lines.  Inset  showing  pfhrp2  and  1  kilobase  flanking  genomic  region.  Large  
866 subtelomeric  deletions  compared  to  the  reference  strain  3D7  are  apparent  in  most  
867 samples.  None  of  the  deletions  involve  pfhrp2  except  the  DD2  strain.   
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869 Supplementary  Figure  8.  Extended  haplotype  homozygosity  centromeric  to  
870 chromosome  8  subtelomeric  structural  profiles  P1-P4  using  MIP  data .  The  only  
871 pfhrp2- deleted  profile  (chr8-P4)  showed  sustained  EHH,  whereas  EHH  quickly  broke  
872 down  for  the  pfhrp2 -intact  profiles  (P1-P3).  A  vertical  dashed  line  on  the  right  marks  
873 the  centromeric  end  of  the  profile  4  ( pfhrp2)  deletion.   
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874   
875
  
876   
877 Supplementary  Figure  9.  Extended  haplotype  homozygosity  (bottom)  and  the  
878 bifurcation  diagrams  showing  haplotype  branching  (top)  centromeric  to  the  
879 pfhrp2  (A)  and  surrounding  pfhrp3  (B)  deletions  based  on  WGS  data .  Vertical  
880 dashed  line  indicating  the  centromeric  end  of  the  chromosome  8  deletion  (A).  Gray  
881 box  demarcating  the  chromosome  13  deletion  (B).  Abbreviations:  Mb,  mega-base.  
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883 Supplementary  Figure  10.  Extended  haplotype  homozygosity  centromeric  to  
884 chromosome  13  subtelomeric  structural  profiles  P1,  P3  and  P4  using  MIP  data .  
885 Chr13-P2  profile  was  observed  in  only  one  sample  and  not  included  in  the  haplotype  
886 analysis.  EHH  quickly  brown  down  for  all  profiles  (P1:  pfhrp3- intact,  P3-P4:  
887 pfhrp3- deleted).  A  vertical  dashed  line  on  the  right  marks  the  centromeric  end  of  the  
888 P3  and  P4  deletions.  No  variants  in  the  duplicated  segment  (gray  box)  were  used  in  
889 the  EHH  analysis.  
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